On 12 March 2018, Medartis Holding AG (Medartis) announced the launch of its initial public offering (IPO) on SIX Swiss Exchange and the first trading day was March 23, 2018. The shares of Medartis were priced at CHF 48 per share, corresponding to a placement volume of CHF 123.9 million (excluding the over-allotment option) and a total market capitalization for Medartis of CHF 563 million. The bank syndicate placed 2,604,166 new registered shares in the base offering. Medartis raised gross proceeds from the IPO of CHF 123.9 million (excluding the over-allotment option).

Medartis is one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures and osteotomies for the craniofacial region as well as for upper and lower extremities. Medartis employs over 480 individuals across its 11 locations, and Medartis products are sold in 44 countries globally.